Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
UTHR
Stock Latest News
The Fly
United Therapeutics price target raised to $435 from $328 at Morgan Stanley
15d ago
UTHR
Premium
The Fly
United Therapeutics price target lowered to $461 from $463 at BofA
16d ago
UTHR
Premium
The Fly
BTIG biotech analyst holds an analyst/industry conference call
21d ago
LQDA
UTHR
Premium
Ratings
Buy Rating for United Therapeutics Driven by Legal Positioning and Market Advantages Amid Patent Litigation
23d ago
UTHR
Premium
Ratings
Hold Rating for United Therapeutics’ Tyvaso Amid Mixed Trial Results and Real-World Applicability Concerns
26d ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $580 from $560 at UBS
26d ago
UTHR
Premium
Ratings
Hold Rating Maintained for United Therapeutics’ Tyvaso Amid Competitive Landscape and Pending Data
26d ago
UTHR
Premium
The Fly
CarMax downgraded, Kenvue upgraded: Wall Street’s top analyst calls
29d ago
V
V
Premium
Ratings
Buy Rating for United Therapeutics Amid Favorable Legal Standing in Patent Litigation
29d ago
UTHR
Premium
The Fly
United Therapeutics initiated with an Outperform at RBC Capital
29d ago
UTHR
Premium
The Fly
United Therapeutics management to meet with Cantor Fitzgerald
1M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $525 from $405 at Cantor Fitzgerald
1M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $575 from $510 at Oppenheimer
2M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $500 from $400 at H.C. Wainwright
2M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $560 from $415 at UBS
2M ago
UTHR
Premium
Ratings
Buy Rating for United Therapeutics: Promising TETON-2 Trial Results Highlight Tyvaso’s Potential in IPF Treatment
2M ago
UTHR
Premium
Ratings
United Therapeutics’ Tyvaso Shines in Phase III Trial, Poised for Growth in IPF Market
2M ago
UTHR
Premium
Ratings
Cautious Optimism for United Therapeutics Amid TETON-2 Success and Market Uncertainties
2M ago
UTHR
Premium
Ratings
United Therapeutics: Hold Rating Amid Positive TETON-2 Results and Competitive Challenges
2M ago
UTHR
Premium
Market News
United Therapeutics Stock (UTHR) Rockets 40% on Clinical Trial Results
2M ago
UTHR
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
AMD
BLK
Premium
The Fly
Kraft Heinz announces separation, Elliott builds $4B PepsiCo stake: Morning Buzz
2M ago
AL
TU
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
